Literature DB >> 169296

Insulin receptor deficiency in genetic and acquired obesity.

A H Soli, C R Kahn, D M Neville, J Roth.   

Abstract

We have previously shown that in the insulin-resistant obese hyperglycemic mouse (ob/ob) there is a deficiency in the number of insulin receptor sites on hepatocytes, adipocytes, and thymic lymphocytes. We now find that concentration of insulin receptors on liver plasma membranes is decreased in the db/db mouse, another form of inherited obesity, and in normal mice that became obese after treatment with gold thioglucose, while thin mice, heterozygous for the ob mutation (ob/+), have normal insulin binding. With acute and chronic food restriction of the ob/ob and gold thioglucose obese mice, there is reduction in hyperinsulinemia and an associated increase in the insulin receptor concentration toward normal. In contrast, when fasting ob/ob mice were given exogenous insulin to maintain the hyperinsulinemia, insulin receptors failed to increase. Thus, in all cases, there was a consistent relationship between the degree of hyperinsulinemia and of insulin receptor loss. These findings suggest that decreased insulin binding is a characteristic feature of the insulin resistance of obesity, and that sustained hyperinsulinemia is a major factor in the control of the concentration of insulin receptors on target cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169296      PMCID: PMC301931          DOI: 10.1172/JCI108155

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  Effect of food restriction on body composition of hereditary obese mice.

Authors:  L G ALONSO; T H MAREN
Journal:  Am J Physiol       Date:  1955-11

3.  Quantitative aspects of the insulin-receptor interaction in liver plasma membranes.

Authors:  C R Kahn; P Freychet; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

4.  Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat.

Authors:  A H Soll; I D Goldfine; J Roth; C R Kahn
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

Review 5.  Peptide hormone binding to receptors: a review of direct studies in vitro.

Authors:  J Roth
Journal:  Metabolism       Date:  1973-08       Impact factor: 8.694

6.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

7.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

8.  Ventromedial hypothalamus and hyperphagia in hyperglycemic obese mice.

Authors:  C A Baile; M G Herrera; J Mayer
Journal:  Am J Physiol       Date:  1970-03

9.  Insulin receptors in human circulating cells and fibroblasts.

Authors:  J R Gavin; J Roth; P Jen; P Freychet
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

10.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

View more
  51 in total

1.  Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision.

Authors:  G S McGee; M M Kulaylat; N N Abumrad
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

Review 2.  Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon.

Authors:  P Freychet
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

Review 3.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

4.  Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.

Authors:  A Carducci Artenisio; F Ragonese; F Forte; G Saitta; G Perrone; G Lettina; R Campisi; F Consolo
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

5.  Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.

Authors:  V Soman; P Felig
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

6.  Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

Authors:  A N Peiris; R A Mueller; G A Smith; M F Struve; A H Kissebah
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

7.  Antidiabetic effects of interleukin 1.

Authors:  A del Rey; H Besedovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Insulin secretion and biosynthesis in sucrose fed rats.

Authors:  H Laube; H Schatz; C Nierle; R Fussgänger; E F Pfeiffer
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

9.  IgE receptors on human basophils. Relationship to serum IgE concentration.

Authors:  F J Malveaux; M C Conroy; N F Adkinson; L M Lichtenstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding.

Authors:  R A DeFronzo; V Soman; R S Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.